CLINICAL_TRIALS
research
· 2025-04-02
Clinical Trial Update: Safety and Efficacy of realSKIN® to Provide Complete Wound Closure of Burn Wounds as an Alternative to Autografting [Phase 3]
Summary
Phase 3 clinical trial update for realSKIN as an alternative to autografting in burn wounds; currently recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: XenoTherapeutics, Inc. | Conditions: Burns Degree Third, Burn (Disorder) | Phase 3 | Status: RECRUITING